CVS Pharmacy Inc. and Rite Aid Corp. accused AstraZeneca Pharmaceuticals on Tuesday of conspiring with three generic drugmakers to delay competition for its blockbuster antipsychotic Seroquel XR.
The antitrust lawsuit, filed in U.S. District Court for the Southern District of New York, targeted patent-infringement settlements AstraZeneca had reached with Handa Pharmaceuticals and Accord Healthcare Inc., which had separately sought regulatory approval to bring generic versions of Seroquel to market.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]